Kronos Bio Balance Sheet Health
Financial Health criteria checks 6/6
Kronos Bio has a total shareholder equity of $159.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $213.3M and $54.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$173.00m |
| Equity | US$159.08m |
| Total liabilities | US$54.20m |
| Total assets | US$213.28m |
Recent financial health updates
Is Kronos Bio (NASDAQ:KRON) In A Good Position To Invest In Growth?
Jan 19
We're Keeping An Eye On Kronos Bio's (NASDAQ:KRON) Cash Burn Rate
Aug 21We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully
Feb 22Is Kronos Bio (NASDAQ:KRON) In A Good Position To Deliver On Growth Plans?
Nov 01Is Kronos Bio (NASDAQ:KRON) In A Good Position To Invest In Growth?
Jul 07We're Hopeful That Kronos Bio (NASDAQ:KRON) Will Use Its Cash Wisely
Feb 01Recent updates
Is Kronos Bio (NASDAQ:KRON) In A Good Position To Invest In Growth?
Jan 19We're Keeping An Eye On Kronos Bio's (NASDAQ:KRON) Cash Burn Rate
Aug 21We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully
Feb 22Is Kronos Bio (NASDAQ:KRON) In A Good Position To Deliver On Growth Plans?
Nov 01Kronos Bio, Invivoscribe to develop companion diagnostic for leukemia drug entospletinib
Aug 16Is Kronos Bio (NASDAQ:KRON) In A Good Position To Invest In Growth?
Jul 07We're Hopeful That Kronos Bio (NASDAQ:KRON) Will Use Its Cash Wisely
Feb 01How Much Of Kronos Bio, Inc. (NASDAQ:KRON) Do Insiders Own?
Mar 03Read This Before Selling Kronos Bio, Inc. (NASDAQ:KRON) Shares
Jan 09
Kronos Bio EPS misses by $4.10
Nov 18Financial Position Analysis
Short Term Liabilities: KRON's short term assets ($178.8M) exceed its short term liabilities ($24.7M).
Long Term Liabilities: KRON's short term assets ($178.8M) exceed its long term liabilities ($29.5M).
Debt to Equity History and Analysis
Debt Level: KRON is debt free.
Reducing Debt: KRON had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: KRON has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: KRON has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 27.8% each year.